TY - JOUR
T1 - Release of bombesin-like immunoreactivity from synaptosomal membranes isolated from the rat ileum
AU - Kurjak, Manfred
AU - Allescher, Hans Dieter
AU - Schusdziarra, Volker
AU - Classen, Meinhard
N1 - Funding Information:
The authors acknowledge the co-operation of Professor Bliimel and his collaborators, Department of Experimental Surgery, Technical University of Munich. We thank S. Wiederer and S. Maguire for expert technical assistance. For electron microscopy pictures we thank Dr. A. Murray from GSF, Neuherberg/Munich and Professor H. H6fler, Department of Pathology, Technical University of Munich. The study was supported by the Deutsche Forschungsgemein-schaft A1 245/2-1 and Schu 492/1-2.
PY - 1994/5/12
Y1 - 1994/5/12
N2 - In the enteric nervous system, direct effects on peptidergic neurotransmitter release are difficult to assess since the neuronal network predisposes to numerous interactions between the various transmitter systems. The aim of the present study was to examine the release of bombesin-like immunoreactivity from isolated nerve synapses of the enteric nervous system. Enriched synaptosomal fractions were obtained by using homogenized tissue from rat ileum, which was subjected to various steps of differential and sucrose density centrifugation. Specific binding of [3H]saxitoxin served as a marker for neuronal membranes. For comparison, the content of bombesin-like immunoreactivity was determined. Both the enriched synaptosomal fraction (mitochondrial fraction II or P2) and the purified synaptosomal fraction (F2), obtained after discontinuous sucrose density centrifugation, showed substantial enrichment of the neuronal marker [3H]saxitoxin and bombesin-like immunoreactivity. The basal release of bombesin-like immunoreactivity was 52±17 pg/mg (100%). KCl-evoked depolarization (65 mM) significantly stimulated the release of bombesin-like immunoreactivity to 142.2% (P<0.05, n = 17). The release was abolished in Ca2+-free medium. Stimulation of the release of bombesin-like immunoreactivity was also observed in the presence of the Ca2+ ionophore A-23187 (10-6 M: 129%, P<0.05, n = 17), supporting the role of Ca2+ in the release process. Cholinergic stimulation with carbachol elicited a significant dose-dependent release of bombesin-like immunoreactivity (10-8 M: 106%, 10-7 M: 175%, P < 0.05, 10-6 M: 156%, P < 0.05, 10-5 M: 115%, n = 14), which was reduced by atropine (10-6 M: 99%, P < 0.01, n = 14). The basal value was 67 ± 9 pg/mg (100%). The different effects of the muscarinic M1 receptor antagonist pirenepzine, which stimulated release of bombesin-like immunoreactivity in combination with carbochol 10-6 M (10-6 M: 123%, n = 10), and of the muscarinic M2 receptor antagonist AFDX 116, which attenuated release of bombesin-like immunoreactivity evoked by carbachol 10-5 M: 66%, P < 0.01, 10-6 M: 88%, n = 10), strongly suggest modulation of the release of bombesin-like immunoreactivity at the presynaptic receptor site through an excitatory muscarinic M2 receptor. The vasal value was 46±9 pg/mg (100%). In summary, bombesin-like immunoreactivity can be released from these synaptosomes by both depolarization with KCl in a Ca2+-dependent manner and by cholinergic stimulation. The synaptosomes of intrinsic nerves of the gut offer an approach to study the release of neuropeptides and neurotransmitters at the subcellular level independent of the ganglionic network.
AB - In the enteric nervous system, direct effects on peptidergic neurotransmitter release are difficult to assess since the neuronal network predisposes to numerous interactions between the various transmitter systems. The aim of the present study was to examine the release of bombesin-like immunoreactivity from isolated nerve synapses of the enteric nervous system. Enriched synaptosomal fractions were obtained by using homogenized tissue from rat ileum, which was subjected to various steps of differential and sucrose density centrifugation. Specific binding of [3H]saxitoxin served as a marker for neuronal membranes. For comparison, the content of bombesin-like immunoreactivity was determined. Both the enriched synaptosomal fraction (mitochondrial fraction II or P2) and the purified synaptosomal fraction (F2), obtained after discontinuous sucrose density centrifugation, showed substantial enrichment of the neuronal marker [3H]saxitoxin and bombesin-like immunoreactivity. The basal release of bombesin-like immunoreactivity was 52±17 pg/mg (100%). KCl-evoked depolarization (65 mM) significantly stimulated the release of bombesin-like immunoreactivity to 142.2% (P<0.05, n = 17). The release was abolished in Ca2+-free medium. Stimulation of the release of bombesin-like immunoreactivity was also observed in the presence of the Ca2+ ionophore A-23187 (10-6 M: 129%, P<0.05, n = 17), supporting the role of Ca2+ in the release process. Cholinergic stimulation with carbachol elicited a significant dose-dependent release of bombesin-like immunoreactivity (10-8 M: 106%, 10-7 M: 175%, P < 0.05, 10-6 M: 156%, P < 0.05, 10-5 M: 115%, n = 14), which was reduced by atropine (10-6 M: 99%, P < 0.01, n = 14). The basal value was 67 ± 9 pg/mg (100%). The different effects of the muscarinic M1 receptor antagonist pirenepzine, which stimulated release of bombesin-like immunoreactivity in combination with carbochol 10-6 M (10-6 M: 123%, n = 10), and of the muscarinic M2 receptor antagonist AFDX 116, which attenuated release of bombesin-like immunoreactivity evoked by carbachol 10-5 M: 66%, P < 0.01, 10-6 M: 88%, n = 10), strongly suggest modulation of the release of bombesin-like immunoreactivity at the presynaptic receptor site through an excitatory muscarinic M2 receptor. The vasal value was 46±9 pg/mg (100%). In summary, bombesin-like immunoreactivity can be released from these synaptosomes by both depolarization with KCl in a Ca2+-dependent manner and by cholinergic stimulation. The synaptosomes of intrinsic nerves of the gut offer an approach to study the release of neuropeptides and neurotransmitters at the subcellular level independent of the ganglionic network.
KW - Bombesin
KW - Ileum
KW - Muscarinic receptor
KW - Nerve varicosity
KW - Neuropeptide release
KW - Synaptosome
UR - https://www.scopus.com/pages/publications/0028361141
U2 - 10.1016/0014-2999(94)90709-9
DO - 10.1016/0014-2999(94)90709-9
M3 - Article
C2 - 8082699
AN - SCOPUS:0028361141
SN - 0014-2999
VL - 257
SP - 169
EP - 179
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1-2
ER -